CMBM Earnings

CMBM reported its earnings on 2025-11-27, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a 1.1% price change on the earnings day and a -17.58% change over the next five days, reflecting market reactions to the results.

Following CMBM's earnings announcement on 2025-11-27, the stock price moved by 1.1% on the day of the release. Over the subsequent five days, it saw a -17.58% change. Historically, CMBM's stock price tends to shift by an average of 0.72% in the 10 days leading up to earnings and -11.36% in the 10 days following, providing insight into potential market.

For 2024/Q4, analysts estimate CMBM's annual revenue to reach 43.20M, while the EPS is projected at -0.13. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CMBM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2024 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CMBM's stock price typically moves by 0.72% in the 10 days before its earnings and -11.36% in the 10 days after. For the upcoming 2024/Q4 earnings, analysts expect an EPS of -0.13 and revenue of 43.20M.

The earnings call presents a mixed picture. Financial performance shows improvement in margins and cash flow, but challenges remain with defense revenue and covenant compliance. Product developments and enterprise growth are positive, yet market competition and economic factors pose risks. The Q&A reveals optimism for gross margin improvements, but uncertainty about defense business and banking issues. Overall, the sentiment is neutral, with balanced positives and negatives, leading to an expected stock price movement within the neutral range of -2% to 2% over the next two weeks.